New Treatment for Generalized Myasthenia Gravis
Presented by:Dr. Gil I. Wolfe, MD, FAAN
Irvin and Rosemary Smith Professor and Chairman
SUNY Distinguished Professor
Dept. of Neurology, Jacobs School of Medicine and Biomedical Sciences
Univ. at Buffalo/SUNY
October 25, 2023 @ 3PM Eastern, 12PM Pacific
Dr. Gil I. Wolfe, MD, FAAN will share educational information about a new targeted treatment for two subtypes of generalized myasthenia gravis (gMG). The webinar will include key details about the first FDA-approved treatment for both anti-AChR (acetylcholine receptor) and anti-MuSK (muscle-specific tyrosine kinase) antibody-positive gMG in adults, including how it works, what patients and caregivers can expect with this treatment, and helpful points for how to talk with a doctor about gMG symptoms and treatment. Sponsored by UCB.